308 related articles for article (PubMed ID: 11860975)
1. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.
Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA
Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975
[TBL] [Abstract][Full Text] [Related]
2. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
Tolentino MJ; Miller JW; Gragoudas ES; Jakobiec FA; Flynn E; Chatzistefanou K; Ferrara N; Adamis AP
Ophthalmology; 1996 Nov; 103(11):1820-8. PubMed ID: 8942877
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.
Wong CG; Rich KA; Liaw LH; Hsu HT; Berns MW
Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.
Tolentino MJ; Miller JW; Gragoudas ES; Chatzistefanou K; Ferrara N; Adamis AP
Arch Ophthalmol; 1996 Aug; 114(8):964-70. PubMed ID: 8694732
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
6. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
7. Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina.
Robbins SG; Conaway JR; Ford BL; Roberto KA; Penn JS
Growth Factors; 1997; 14(4):229-41. PubMed ID: 9386988
[TBL] [Abstract][Full Text] [Related]
8. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.
Adamis AP; Shima DT; Tolentino MJ; Gragoudas ES; Ferrara N; Folkman J; D'Amore PA; Miller JW
Arch Ophthalmol; 1996 Jan; 114(1):66-71. PubMed ID: 8540853
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
Mathews MK; Merges C; McLeod DS; Lutty GA
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
[TBL] [Abstract][Full Text] [Related]
11. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys.
Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO
Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.
Hofman P; van Blijswijk BC; Gaillard PJ; Vrensen GF; Schlingemann RO
Arch Ophthalmol; 2001 Jun; 119(6):861-6. PubMed ID: 11405837
[TBL] [Abstract][Full Text] [Related]
13. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
15. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
16. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
19. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.
Clermont AC; Aiello LP; Mori F; Aiello LM; Bursell SE
Am J Ophthalmol; 1997 Oct; 124(4):433-46. PubMed ID: 9323935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
